Microsoft Excel LibreOffice Calc

Celgene Corp. (CELG)


Liquidity Analysis

Difficulty: Beginner


Ratios (Summary)

Celgene Corp., liquidity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Current ratio 2.23 4.99 3.67 4.77 4.60
Quick ratio 2.00 4.67 3.24 4.05 4.13
Cash ratio 1.49 4.03 2.69 3.33 3.57

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).

Ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Celgene Corp.’s current ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Celgene Corp.’s quick ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Celgene Corp.’s cash ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.

Current Ratio

Celgene Corp., current ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in millions)
Current assets 9,067  14,892  10,868  9,401  9,713 
Current liabilities 4,057  2,987  2,959  1,969  2,112 
Ratio
Current ratio1 2.23 4.99 3.67 4.77 4.60
Benchmarks
Current Ratio, Competitors
Abbott Laboratories 1.62 2.26 4.02 1.54 1.45
AbbVie Inc. 0.98 1.28 1.65 1.50 1.41
Allergan PLC 1.13 1.16 2.27 1.03 1.37
Amgen Inc. 2.79 5.49 4.11 4.44 4.95
Biogen Inc. 2.32 2.34 2.55 2.60 2.11
Bristol-Myers Squibb Co. 1.61 1.55 1.55 1.30 1.73
Eli Lilly & Co. 1.73 1.32 1.37 1.53 1.09
Gilead Sciences Inc. 3.38 2.74 2.22 2.50 3.07
Johnson & Johnson 1.47 1.41 2.47 2.17 2.36
Merck & Co. Inc. 1.17 1.33 1.78 1.55 1.77
Pfizer Inc. 1.57 1.35 1.25 1.49 2.67
Regeneron Pharmaceuticals Inc. 4.47 3.82 2.56 3.59 3.31
Current Ratio, Sector
Pharmaceuticals & Biotechnology 1.70 1.82 2.14 1.92 2.19
Current Ratio, Industry
Health Care 1.52 1.64 1.83 1.73 1.98

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).

2018 Calculations

1 Current ratio = Current assets ÷ Current liabilities
= 9,067 ÷ 4,057 = 2.23

Ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Celgene Corp.’s current ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.

Quick Ratio

Celgene Corp., quick ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in millions)
Cash and cash equivalents 4,234  7,013  6,170  4,880  4,122 
Debt securities available-for-sale 496  3,219  –  –  – 
Equity investments with readily determinable fair values 1,312  1,810  –  –  – 
Marketable securities available-for-sale –  –  1,800  1,672  3,425 
Accounts receivable, net of allowances 2,066  1,921  1,621  1,421  1,167 
Total quick assets 8,108  13,963  9,590  7,973  8,713 
Current liabilities 4,057  2,987  2,959  1,969  2,112 
Ratio
Quick ratio1 2.00 4.67 3.24 4.05 4.13
Benchmarks
Quick Ratio, Competitors
Abbott Laboratories 1.03 1.67 3.31 1.04 0.76
AbbVie Inc. 0.78 0.89 1.14 1.21 1.06
Allergan PLC 0.83 0.95 2.00 0.42 0.52
Amgen Inc. 2.44 4.98 3.68 3.97 4.22
Biogen Inc. 1.83 1.78 1.94 1.93 1.54
Bristol-Myers Squibb Co. 1.37 1.30 1.27 1.05 1.26
Eli Lilly & Co. 1.20 0.91 0.98 1.04 0.77
Gilead Sciences Inc. 3.15 2.52 1.78 2.07 2.56
Johnson & Johnson 1.08 1.04 2.04 1.77 1.76
Merck & Co. Inc. 0.72 0.83 1.24 1.04 1.19
Pfizer Inc. 0.84 0.93 0.84 1.07 2.07
Regeneron Pharmaceuticals Inc. 3.50 2.98 2.13 3.10 2.93
Quick Ratio, Sector
Pharmaceuticals & Biotechnology 1.27 1.42 1.69 1.48 1.63
Quick Ratio, Industry
Health Care 1.13 1.29 1.44 1.33 1.48

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).

2018 Calculations

1 Quick ratio = Total quick assets ÷ Current liabilities
= 8,108 ÷ 4,057 = 2.00

Ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Celgene Corp.’s quick ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.

Cash Ratio

Celgene Corp., cash ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in millions)
Cash and cash equivalents 4,234  7,013  6,170  4,880  4,122 
Debt securities available-for-sale 496  3,219  –  –  – 
Equity investments with readily determinable fair values 1,312  1,810  –  –  – 
Marketable securities available-for-sale –  –  1,800  1,672  3,425 
Total cash assets 6,042  12,042  7,970  6,552  7,547 
Current liabilities 4,057  2,987  2,959  1,969  2,112 
Ratio
Cash ratio1 1.49 4.03 2.69 3.33 3.57
Benchmarks
Cash Ratio, Competitors
Abbott Laboratories 0.45 1.08 2.82 0.67 0.42
AbbVie Inc. 0.47 0.59 0.66 0.77 0.73
Allergan PLC 0.33 0.65 1.68 0.13 0.05
Amgen Inc. 2.17 4.62 3.40 3.62 3.86
Biogen Inc. 1.07 1.10 1.43 1.33 0.83
Bristol-Myers Squibb Co. 0.83 0.71 0.72 0.53 0.88
Eli Lilly & Co. 0.68 0.55 0.55 0.54 0.43
Gilead Sciences Inc. 2.84 2.19 1.29 1.48 1.76
Johnson & Johnson 0.63 0.60 1.59 1.38 1.32
Merck & Co. Inc. 0.40 0.46 0.83 0.70 0.84
Pfizer Inc. 0.59 0.66 0.57 0.79 1.67
Regeneron Pharmaceuticals Inc. 1.95 1.24 0.84 1.29 1.38
Cash Ratio, Sector
Pharmaceuticals & Biotechnology 0.87 1.03 1.29 1.08 1.21
Cash Ratio, Industry
Health Care 0.73 0.90 1.03 0.94 1.07

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).

2018 Calculations

1 Cash ratio = Total cash assets ÷ Current liabilities
= 6,042 ÷ 4,057 = 1.49

Ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Celgene Corp.’s cash ratio improved from 2016 to 2017 but then deteriorated significantly from 2017 to 2018.